Clincosm LogoSign in Get a demo

cholangiocarcinoma, intrahepatic

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))

Recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Shanghai, China
    Lulu@Huashan.Org.Cn
Aug 16, 2022

Hepatocellular Carcinoma, Cholangiocarcinoma, Intrahepatic Trial in Belgium, France, United States (GNS561)

Terminated
  • Hepatocellular Carcinoma
  • Cholangiocarcinoma, Intrahepatic
  • New York, New York
  • +4 more
Apr 25, 2022

Cholangiocarcinoma, Intrahepatic Trial in Toronto (Liver Transplantation)

Enrolling by invitation
  • Cholangiocarcinoma, Intrahepatic
  • Liver Transplantation
  • Toronto, Ontario, Canada
    University Health Network
Apr 8, 2022

Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Recombinant Human Adenovirus Type 5
  • HAIC of FOLFOX
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Mar 16, 2022

Cholangiocarcinoma, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Perihilar Trial (ABC294640)

Available
  • Cholangiocarcinoma
  • +4 more
  • (no location specified)
Mar 14, 2022

Biliary Stones, Cholangiocarcinoma, Intrahepatic, Biliary Stricture Trial in Baltimore (Percutaneous cholangiopancreatoscopy)

Recruiting
  • Biliary Stones
  • +4 more
  • Percutaneous cholangiopancreatoscopy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jan 13, 2022

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Lenvatinib combined with gemox, Toripalimab combined with lenvatinib)

Active, not recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Lenvatinib combined with gemox
  • Toripalimab combined with lenvatinib
  • Shanghai, China
  • +1 more
Jul 5, 2021

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (combined therapy using oxaliplatin and gemcitabine chemo, Lenvatinib and PD1

Active, not recruiting
  • Cholangiocarcinoma, Intrahepatic
  • combined therapy using oxaliplatin and gemcitabine chemotherapy, Lenvatinib and PD1 antibody (JS001)
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jul 5, 2021

HCC - Prospective German Multicenter Study

Completed
  • Hepatocellular Carcinoma
  • +5 more
  • contrast enhanced ultrasound (CEUS)
  • +2 more
  • Erlangen, Bavaria, Germany
    University Hospital Erlangen, Department of Medicine 1
Feb 28, 2021

Cholangiocarcinoma, Intrahepatic, PD-L1, CTLA4 Trial in Shanghai (PD-L1 antibody combined with CTLA-4 antibody)

Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • +2 more
  • PD-L1 antibody combined with CTLA-4 antibody
  • Shanghai, China
    Zhongshan hospital
Nov 17, 2020

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (GC combined Lenvatinib)

Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • GC combined Lenvatinib
  • Shanghai, China
    Zhongshan hospital
Aug 23, 2020

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (neoadjuvant treatment)

Recruiting
  • Cholangiocarcinoma, Intrahepatic
  • neoadjuvant treatment
  • Shanghai, Shanghai, China
    Zhongshan hospital
Aug 7, 2020

Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic Trial in Korea, Republic

Terminated
Has Results
  • Cholangiocarcinoma Non-resectable
  • +3 more
  • Phoenix, Arizona
  • +35 more
Jan 24, 2020

Surgery for Recurrent Intrahepatic Cholangiocarcinoma

Completed
  • Cholangiocarcinoma, Intrahepatic
  • +2 more
  • hepatectomy
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital Linkou Branch
Sep 11, 2019

Cholangiocarcinoma, Intrahepatic Trial (combined therapy using nab-paclitaxel and gemcitabine chemo)

Unknown status
  • Cholangiocarcinoma, Intrahepatic
  • combined therapy using nab-paclitaxel and gemcitabine chemotherapy
  • (no location specified)
Sep 3, 2019